Anodyne

Tranylcypromine
Generated by the Chemistry Development Kit (http://github.com/cdk)
Molecular structure via molpic based on CDK
Physical properties
[]
133.19 g/mol [1]
AppearanceLiquid [1]
Melting point79-80 °C at 1.50E+00 mm Hg [1]
Boiling point79-80 °C @ 1.5-1.6 mm Hg [1]
SolubilitySol in water /Sulfate/ [1]
1.5 [1]
Structural Identifiers
[]
C9H11[1]
2-phenylcyclopropan-1-amine [1]
C1C(C1N)C2=CC=CC=C2 [1]
InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2 [1]
InChIKeyAELCINSCMGFISI-UHFFFAOYSA-N [1]
Pharmacokinetics[]
Elimination half-life2.5 hours

Tranylcypromine

Tranylcypromine (also known as Tranylcypromine, tranylcypromine, Transamine, Racemic Tranylcypromine, SKF 385, Jatrosom, Parnitene, Tranilcipromina, Tranylcyprominum or Cyclopropanamine, 2-phenyl-, trans-(+-)-) is a monoamine oxidase inhibitor substance of the phenylcyclopropylamine class.

Chemistry

 []

Tranylcypromine is a racemic mixture of the

Stereoisomers
(1S,2R)-TranylcypromineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(1R,2R)-TranylcypromineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(1S,2S)-TranylcypromineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(1R,2S)-TranylcypromineGenerated by the Chemistry Development Kit (http://github.com/cdk)

Legal status []

  • Australia: Tranylcypromine is a S4 substance.
  • Brazil: Tranylcypromine is a C1 substance.[2]
  • Canada: Tranylcypromine is a prescription only substance.
  • United Kingdom: Tranylcypromine is a prescription only substance.
  • United States: Tranylcypromine is a prescription only substance.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5530, Tranylcypromine. Accessed October 9, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/5530

  2. Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed October 9, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992